Cg Oncology Inc’s filing revealed that its Director POST LEONARD E unloaded Company’s shares for reported $28000.0 on May 21 ’25. In the deal valued at $28.00 per share,1,000 shares were sold. As a result of this transaction, POST LEONARD E now holds 0 shares worth roughly $0.0.
Then, POST LEONARD E sold 1,000 shares, generating $30,760 in total proceeds. Upon selling the shares at $30.76, the Director now owns 0 shares.
Before that, POST LEONARD E sold 1,000 shares. Cg Oncology Inc shares valued at $28,000 were divested by the Director at a price of $28.00 per share. As a result of the transaction, POST LEONARD E now holds 0 shares, worth roughly $0.0.
JP Morgan initiated its Cg Oncology Inc [CGON] rating to an Overweight in a research note published on May 02, 2025; the price target was $41. A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in mid April with a ‘”a Sector perform”‘ rating. TD Cowen began covering CGON with “Buy” recommendation on January 07, 2025. UBS started covering the stock on October 24, 2024. It rated CGON as “a Buy”.
Price Performance Review of CGON
On Monday, Cg Oncology Inc [NASDAQ:CGON] saw its stock jump 3.79% to $26.59. Over the last five days, the stock has gained 4.52%. Cg Oncology Inc shares have fallen nearly -7.29% since the year began. Nevertheless, the stocks have fallen -17.93% over the past one year. While a 52-week high of $40.47 was reached on 04/28/25, a 52-week low of $14.80 was recorded on 04/09/25. SMA at 50 days reached $23.65, while 200 days put it at $30.40.
Levels Of Support And Resistance For CGON Stock
The 24-hour chart illustrates a support level at 25.72, which if violated will result in even more drops to 24.86. On the upside, there is a resistance level at 27.20. A further resistance level may holdings at 27.82. The Relative Strength Index (RSI) on the 14-day chart is 57.03, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.63, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 31.01%. Stochastics %K at 59.63% indicates the stock is a holding.
The most recent change occurred on September 23, 2024 when RBC Capital Mkts began covering the stock and recommended ‘”an Outperform”‘ rating along with a $66 price target.
